NCT04013048View on ClinicalTrials.gov

Study to Evaluate the Mass Balance and Biotransformation of [14C]-Fluzoparib in Chinese Patients With Solid Tumor

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 8, 2019

Primary Completion Date

December 24, 2019

Study Completion Date

December 24, 2019

Conditions

Solid Tumor

Interventions

DRUG

[14C]-Fluzoparib

Patients will receive single dose of orally \[14C\]- Fluzoparib on Day 1.

Trial Locations (1)

215006

The First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04013048 - Study to Evaluate the Mass Balance and Biotransformation of [14C]-Fluzoparib in Chinese Patients With Solid Tumor | Biotech Hunter | Biotech Hunter